Nature's BioCeuticals Denmark ApS: Financial statements 2023
CVR: 41912367
Source: annual report 2023, Danish Business Authority
01/07/2022 – 30/06/2023
Nature's BioCeuticals Denmark ApS (CVR 41912367) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -848,625 and a net result of DKK -1,434,890 compared with DKK -1,517,144 the year before. Equity in the 2023 report amounted to DKK -1,152,050.
- Gross Profit
- DKK -848,625
- Profit/Loss
- DKK -1,434,890
- Equity
- DKK -1,152,050
- Total Assets
- DKK 14,051,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -849K | -1.4M | -1.2M | - |
| 2022 | - | -944K | -1.5M | -1.5M | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Nature's BioCeuticals Denmark ApS has published its annual report for 2022. Gross profit came to DKK -943,913, and the net result was DKK -1,517,144.
As of March 30, 2023, Francois Jean Martin Susini is registered as adm. dir. of Nature's BioCeuticals Denmark ApS.
As of March 30, 2023, is registered as an owner of Nature's BioCeuticals Denmark ApS with an ownership share of 90%.
As of February 8, 2023, Francois Jean-Martin Susini has stepped down as director of Nature's BioCeuticals Denmark ApS.
About Nature's BioCeuticals Denmark ApS
Nature's BioCeuticals Denmark ApS is a Danish company of the type Anpartsselskab based in Odense M, founded in 2020. The company is registered under the industry Fremstilling af farmaceutiske råvarer. The company was previously named Egehoj Development ApS. The management consists of Francois Jean Martin Susini. The company is owned by Green Vault Group. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK -129,477 and a net result of DKK -611,024 compared with DKK -897,649 the year before. Equity in the 2025 report amounted to DKK 12,151,659.